Related Experiment Video
Updated: Nov 8, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
BC-TFdb: a database of transcription factor drivers in breast cancer
Abbas Khan1, Taimoor Khan1, Syed Nouman Nasir2
1Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.
Abstract:
Transcription factors (TFs) are DNA-binding proteins, which regulate many essential biological functions. In several cancer types, TF function is altered by various direct mechanisms, including gene amplification or deletion, point mutations, chromosomal translocations, expression alterations, as well as indirectly by non-coding DNA mutations influencing the binding of the TF. TFs are also actively involved in breast cancer (BC) initiation and progression. Herein, we have developed an open-access database, BC-TFdb (Breast Cancer Transcription Factors database), of curated, non-redundant TF involved in BC. The database provides BC driver TFs related information including genomic sequences, proteomic sequences, structural data, pathway information, mutations information, DNA binding residues, survival and therapeutic resources. The database will be a useful platform for researchers to obtain BC-related TF-specific information. High-quality datasets are downloadable for users to evaluate and develop computational methods for drug designing against BC. Database URL: https://www.dqweilab-sjtu.com/index.php.
Insights
Researchers have created BC-TFdb, a new database for breast cancer (BC) transcription factors (TFs). This resource offers curated data to aid in understanding TF roles and developing new drug designs for BC.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- Transcription factors (TFs) are crucial DNA-binding proteins regulating biological functions.
- Altered TF function, through genetic or expression changes, contributes to cancer development, including breast cancer (BC).
- Understanding TF involvement in BC is vital for targeted therapies.
Purpose of the Study:
- To develop BC-TFdb, an open-access, curated database of transcription factors involved in breast cancer.
- To provide comprehensive information on BC-related TFs, including genomic, proteomic, structural, and functional data.
- To facilitate research in BC by offering downloadable datasets for computational method development and drug design.
Main Methods:
- Curated collection of non-redundant transcription factors implicated in breast cancer.
- Integration of diverse data types: genomic and proteomic sequences, structural data, pathway information, mutation data, DNA binding residues, and survival/therapeutic resources.
- Development of an accessible online platform for data retrieval and download.
Main Results:
- Establishment of BC-TFdb, a centralized resource for breast cancer transcription factors.
- BC-TFdb provides detailed information on BC driver TFs, including sequence, structure, pathways, mutations, and clinical relevance.
- Downloadable high-quality datasets are available for further research and computational analysis.
Conclusions:
- BC-TFdb serves as a valuable platform for researchers investigating the role of TFs in breast cancer.
- The database supports the exploration of TF-specific information and aids in the development of computational approaches for BC drug discovery.
- BC-TFdb promotes advancements in understanding and treating breast cancer through accessible, curated TF data.
Related Concept Videos
Transcription Factors
General Transcription Factors
Master Transcription Regulators
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Co-activators and Co-repressors
Co-activators and Co-repressors

